![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 12
Zeitschriftenartikel
Hayden, P. J.; Roddie, C.; Bader, P.; Basak, G. W.; Bonig, H.; Bonini, C.; Chabannon, C.; Ciceri, F.; Corbacioglu, S.; Ellard, R.; Sanchez-Guijo, F.; Jaeger, U.; Hildebrandt, M.; Hudecek, M.; Kersten, M. J.; Koehl, U.; Kuball, J.; Mielke, S.; Mohty, M.; Murray, J.; Nagler, A.; Rees, J.; Rioufol, C.; Saccardi, R.; Snowden, J. A.; Styczynski, J.; Subklewe, M.; Thieblemont, C.; Topp, M.; Ispizua, A. U.; Chen, D.; Vrhovac, R.; Gribben, J. G.; Kroeger, N.; Einsele, H. und Yakoub-Agha, I
(2022):
Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA).
In: Annals of Oncology, Bd. 33, Nr. 3: S. 259-275
Ringden, O.; Labopi, M.; Sadeghi, B.; Mailhol, A.; Beelen, D.; Floisand, Y.; Ghavamzadeh, A.; Finke, J.; Ehninger, G.; Volin, L.; Socie, G.; Kröger, N.; Stuhler, G.; Ganser, A.; Schmid, C.; Giebel, S.; Mohty, M. und Nagler, A.
(2018):
What is the outcome in patients with acute leukaemia who survive severe acute graft-versus-host disease?
In: Journal of Internal Medicine, Bd. 283, Nr. 2: S. 166-177
Craddock, C.; Versluis, J.; Labopin, M.; Socie, G.; Huynh, A.; Deconinck, E.; Volin, L.; Milpied, N.; Bourhis, J. H.; Rambaldi, A.; Chevallier, P.; Blaise, D.; Manz, M.; Vellenga, E.; Vekemans, M-C.; Maertens, J.; Passweg, J.; Vyas, P.; Schmid, C.; Lowenberg, B.; Ossenkoppele, G.; Mohty, M.; Cornelissen, J. J. und Nagler, A.
(2018):
Distinct factors determine the kinetics of disease relapse in adults transplanted for acute myeloid leukaemia.
In: Journal of Internal Medicine, Bd. 283, Nr. 4: S. 371-379
Nasso, D.; Labopin, M.; Ruggeri, A.; Ciceri, F.; Lint, M. T. van; Arcese, W.; Tischer, J.; Blaise, D.; Ehninger, G.; Koc, Y.; Santarone, S.; Bruno, B.; Huang, X.-J.; Savani, B. N.; Mohty, M. und Nagler, A.
(2017):
Impact of Conditioning Regimen on Outcomes of T-Replete Haplo-Identical Transplantation for Patients Over 45 Years-Old with AML: A Study On Behalf Of the Acute Leukemia Working Party of the EBMT.
In: Haematologica, Bd. 102: S. 132
Vrhovac, R.; Labopin, M.; Ciceri, F.; Finke, J.; Holler, E.; Tischer, J.; Lioure, B.; Gribben, J.; Kanz, L.; Blaise, D.; Dreger, P.; Held, G.; Arnold, R.; Nagler, A. und Mohty, M.
(2016):
Second reduced intensity conditioning allogeneic transplant as a rescue strategy for acute leukaemia patients who relapse after an initial RIC allogeneic transplantation: analysis of risk factors and treatment outcomes.
In: Bone Marrow Transplantation, Bd. 51, Nr. 2: S. 186-193
Tsirigotis, P.; Byrne, M.; Schmid, C.; Baron, F.; Ciceri, F.; Esteve, J.; Gorin, N. C.; Giebel, S.; Mohty, M.; Savani, B. N. und Nagler, A.
(2016):
Relapse of AML after hematopoietic stem cell transplantation: methods of monitoring and preventive strategies. A review from the ALWP of the EBMT.
In: Bone Marrow Transplantation, Bd. 51, Nr. 11: S. 1431-1438
Dietrich, S.; Finel, H.; Martinez, C.; Tischer, J.; Blaise, D.; Chevallier, P.; Castagna, L.; Milpied, N.; Bacigalupo, A.; Corradini, P.; Mohty, M.; Sanz, M.; Hausmann, A.; Montoto, S.; Robinson, S.; Boumendil, A.; Sureda, A. und Dreger, P.
(2016):
Post-transplant cyclophosphamide-based haplo-identical transplantation as alternative to matched sibling or unrelated donor transplantation for non-Hodgkin lymphoma: a registry study by the European society for blood and marrow transplantation.
In: Leukemia, Bd. 30, Nr. 10: S. 2086-2089
Baron, F.; Ruggeri, A.; Beohou, E.; Labopin, M.; Sanz, G.; Milpied, N.; Michallet, M.; Socie, G.; Blaise, D.; Sierra, J.; Cornelissen, J.; Mohty, M.; Schmid, C.; Giebel, S.; Gorin, N. C.; Esteve, J.; Ciceri, F.; Savani, B.; Gluckman, E. und Nagler, A.
(2016):
Impact of dose intensity on unrelated cord blood transplantation outcomes in adults patients with acute leukemia: A Report from Eurocord, the ALWP and the Cord Blood Committee of the CTIWP of the EBMT.
In: Bone Marrow Transplantation, Bd. 51:
S278-S279
Brissot, E.; Labopin, M.; Ciceri, F.; Bornhäuser, M.; Tischer, J.; Stelljes, M.; Koc, Y.; Stuhler, G.; Fanin, R.; Ganser, A.; Glass, B.; Mohty, M. und Nagler, A.
(2016):
Comparison of haplo-identical versus unrelated allogeneic stem cell transplantation for acute myeloid leukemia with active disease: A report of 1578 patients from Acute Leukemia Working Party of EBMT.
In: Bone Marrow Transplantation, Bd. 51:
S65-S65
Lorentino, F.; Ciceri, F.; Labopin, M.; Ruggeri, A.; Guelbas, Z.; Koc, Y.; Arcese, W.; Bruno, B.; Tischer, J.; Lint, M. T. van; Blaise, D.; Messina, G.; Bornhaeuser, M.; Fleischhauer, K.; Beelen, D. W.; Nagler, A. und Mohty, M.
(2016):
HLA disparities on unshared haplotype influence outcomes of unmanipulated haploidentical hematopoietic stem cell transplantation (HaploSCT): A Study from the Acute Leukemia Working Party of European Society for Blood and Marrow Transplantation (EBMT).
In: Bone Marrow Transplantation, Bd. 51:
S28-S29
Malard, F.; Labopin, M.; Stuhler, G.; Bittenbring, J.; Ganser, A.; Tischer, J.; Michallet, M.; Kroeger, N.; Schmid, C.; Huynh, A.; Hallek, M.; Savani, B.; Mohty, M. und Nagler, A.
(2016):
Sequential intensified conditioning regimen allogeneic hematopoietic stem cell transplantation in adult patients with high-risk AML in complete remission: a survey from the ALWP of the EBMT.
In: Bone Marrow Transplantation, Bd. 51:
S11-S11
Ringden, O.; Labopin, M.; Schmid, C.; Sadeghi, B.; Polge, E.; Tischer, J.; Ganser, A.; Michallet, M.; Kanz, L.; Schwerdtfeger, R.; Nagler, A. und Mohty, M.
(2016):
Sequential chemotherapy followed by reduced intensity conditioning and allogeneic hematopoietic stem cell transplantation in adult patients with relapse or refractory acute myeloid leukemia (AML): a survey from the Acute Leukemia Working Party of EBMT.
In: Bone Marrow Transplantation, Bd. 51:
S476-S477